People who stop using Mounjaro suffer reversal of health benefits, says study
Ceasing use of jabs brings regained weight plus loss of benefits regarding ‘bad’ cholesterol and blood pressure
People who stop using the weight-loss jab Mounjaro not only tend to regain weight, but experience a reversal in other health improvements too, research suggests.
Mounjaro, which contains the active ingredient tirzepatide, has become a popular medication for weight loss, with studies suggesting that it can help people lose an
average of 20% of their body weight after 72 weeks of treatment.
However, research has previously found that people who stop using tirzepatide tend to
regain much of the weight they have lost.
Now experts studying results from a clinical trial known as Surmount-4 say other benefits seen with the medication, such as reduced blood pressure and lower levels of “bad” cholesterol, also go into reverse upon stopping the jabs.
Naveed Sattar, a professor of cardiometabolic medicine at the University of Glasgow who was not part of the team but was involved with previous work on the trial, said “the findings are not a surprise, as excess weight is a well-established driver of elevated blood pressure and impaired glucose control”.
He added: “Consequently, when weight lost through therapeutic interventions is regained, these cardiometabolic risk factors typically rise in proportion to the speed and extent of weight regain.
Ceasing use of jabs brings regained weight plus loss of benefits regarding ‘bad’ cholesterol and blood pressure
www.theguardian.com